Current location - Education and Training Encyclopedia - University ranking - Shenyang Pharmaceutical University Postgraduate Admission Scores
Shenyang Pharmaceutical University Postgraduate Admission Scores
According to the query of the college students' essential network, the graduate scores of Shenyang Medical University are different. The following are some professional scores for reference only:

In philosophy major, in 2023, there were 323 points for graduate students in Shenyang Medical University, and 3 13 points for graduate students in class B; Economics major, in 2023, Shenyang Medical University graduate students scored 346 points for Class A candidates and 336 points for Class B candidates; Medicine (excluding Chinese medicine nursing major) In 2023, Shenyang Medical University graduate students scored 296 points for Class A candidates and 286 points for Class B candidates; In the nursing major of traditional Chinese medicine, in 2023, Shenyang Medical University graduate students scored 295 points for Class A candidates and 285 points for Class B candidates; In 2023, Shenyang Medical University graduate students scored 362 points for Class A candidates and 352 points for Class B candidates. In 2023, Shenyang Medical University graduate students scored 25 1 point for Class A candidates and 24 1 point for Class B candidates.

Shenyang Pharmaceutical University, located in Shenyang, Liaoning Province, is a provincial comprehensive pharmaceutical university. It has successively been selected into key universities in Liaoning Province, national postgraduate plan for building high-level universities, national key discipline plan, 2.0 base for training top students in basic disciplines, national base for training talents in basic science research and teaching, national base for training talents in life sciences and technology, national drug supervision and research base, national college students' innovation and entrepreneurship training plan, national experimental zone for innovation of talent training mode, the first batch of national doctoral and master's degree awarding units, and Industry-University-Research strategic alliance of national innovative drugs.